TL;DR
Age-related macular degeneration (AMD) stands as the leading cause of vision loss amongst individuals over 50 in the United Kingdom, affecting hundreds of thousands of people across the nation.
This progressive eye condition targets the macula – a tiny but crucial area of the retina responsible for our sharpest, most detailed central vision.
Understanding the differences between dry and wet AMD is essential for anyone concerned about their eye health, as these two forms of the disease present vastly different challenges, treatment options, and prognoses.
Understanding macular degeneration
The macula, measuring just 5.5 millimetres in diameter, contains the highest concentration of light-sensitive cells called photoreceptors in the entire retina. This small region enables us to read fine print, recognise faces, drive safely, and perform countless daily activities that require detailed vision.
When AMD develops, it specifically attacks this vital area, leaving peripheral vision largely intact whilst compromising the central vision we rely upon most.
Research indicates that approximately 25.3% of Europeans over 60 have early or intermediate AMD, with 2.4% experiencing late-stage disease.
Dry macular degeneration (the gradual threat)
Dry AMD, also known as non-neovascular AMD, represents the more common form of the disease, accounting for approximately 80-90% of all AMD cases.
This type of macular degeneration typically develops slowly over years or even decades, often beginning so subtly that many individuals remain unaware of its presence until significant changes have occurred.
How dry AMD develops
The hallmark of dry AMD lies in the formation of drusen – tiny yellow or white deposits that accumulate beneath the retina like sediment settling at the bottom of a river.
Whilst small drusen naturally occur with age and pose no threat, larger and more numerous drusen signal the onset of AMD. These deposits interfere with the normal functioning of the retinal pigment epithelium (RPE), a critical layer that supports and nourishes the photoreceptors.
As dry AMD progresses, the affected retinal cells begin to thin and gradually die off, a process called geographic atrophy. This cellular death occurs in patches, creating blind spots in the central visual field that expand over time. The progression through three distinct stages – early, intermediate, and advanced – can span many years, providing opportunities for intervention and lifestyle modifications.
Recognising the symptoms
The symptoms of dry AMD often develop so gradually that they may be mistaken for normal ageing changes. Early warning signs include:
- Blurred or slightly hazy central vision, particularly noticeable when reading
- Increased difficulty adapting to low-light conditions, such as when entering a dimly lit restaurant
- Need for progressively brighter lighting when reading or performing close work
- Colours appearing less vibrant or washing out
- Straight lines beginning to appear slightly wavy or distorted
- A gradual enlargement of blind spots in central vision
Many individuals first notice these changes when covering one eye, as the unaffected eye often compensates for early vision loss in the affected eye.
Treatment approaches for dry AMD
Currently, no cure exists for dry AMD, but several evidence-based approaches can significantly slow its progression. The landmark Age-Related Eye Disease Study (AREDS) demonstrated that specific nutritional supplements can reduce the risk of progression to advanced AMD by approximately 25% in individuals with intermediate-stage disease.
Nutritional intervention
High-dose antioxidant vitamins and minerals, including vitamin C, vitamin E, beta-carotene (or lutein and zeaxanthin for smokers), zinc, and copper, form the foundation of nutritional therapy. These supplements work by reducing oxidative stress and inflammation in the retina.
Lifestyle modifications
Research consistently shows that certain lifestyle changes can dramatically impact AMD progression:
- Stopping smoking represents the single most important modifiable risk factor
- Maintaining a diet rich in leafy green vegetables, fish high in omega-3 fatty acids, and colourful fruits and vegetables
- Regular cardiovascular exercise to improve circulation to the retina
- Protecting eyes from harmful UV radiation with quality sunglasses
Monitoring and early detection
Regular comprehensive eye examinations with dilated pupils allow for early detection and monitoring of AMD progression. The Amsler grid test, performed at home, can help detect subtle changes in central vision between examinations.
Related read: How Often Should You Get An Eye Exam?
Wet macular degeneration (the aggressive form)
Wet AMD, also called advanced neovascular AMD, is a less common type of late AMD that usually causes faster vision loss.
Though it accounts for only 10-15% of all AMD cases, wet AMD is responsible for approximately 90% of severe vision loss associated with macular degeneration. This dramatic disparity highlights the aggressive nature of wet AMD and explains why it’s generally considered the more serious form of the disease.
The mechanism behind wet AMD
Wet AMD develops when the eye attempts to compensate for the damage caused by dry AMD through a process called choroidal neovascularisation. In response to reduced oxygen and nutrient supply to the retina, the body releases vascular endothelial growth factor (VEGF), a protein that stimulates the growth of new blood vessels.
Unfortunately, these new vessels grow in the wrong place – beneath the retina – and are inherently fragile and leaky. Unlike the well-established blood vessels elsewhere in the eye, these abnormal vessels lack proper structural support and readily leak fluid, blood, and other materials into the surrounding retinal tissue.
TThis leakage causes the macula to swell and distort, rapidly disrupting the precise alignment of photoreceptors necessary for sharp central vision. Over time, the chronic inflammation and scarring that result from this process can permanently damage the retinal architecture.
Recognising wet AMD symptoms
The symptoms of wet AMD often appear suddenly and worsen rapidly, making prompt medical attention crucial. Key warning signs include:
- Sudden onset of blurred or distorted central vision
- Straight lines appearing wavy, bent, or broken (metamorphopsia)
- Dark or empty areas appearing in central vision (scotomas)
- Colours appearing duller or different between the two eyes
- Rapid worsening of vision over days or weeks
- Difficulty recognising faces or reading
The Amsler grid test proves particularly valuable for detecting wet AMD, as the characteristic distortion of straight lines often appears before other symptoms become apparent.
Advanced treatment options for wet AMD
The introduction of anti-VEGF therapy has revolutionised wet AMD treatment, transforming what was once considered an untreatable condition into a manageable disease for many patients. These treatments work by blocking the VEGF protein responsible for abnormal blood vessel growth.
Anti-VEGF injections
The cornerstone of wet AMD treatment involves regular intravitreal injections of medications such as ranibizumab (Lucentis), aflibercept (Eylea), or bevacizumab (Avastin). These injections, administered directly into the vitreous cavity of the eye, can halt or slow vision loss and, in some cases, actually improve vision.
Treatment typically begins with monthly injections for the first few months, followed by ongoing injections at intervals determined by individual response. The injection risks are relatively low, with approximately a one in a thousand chance of serious complications such as retinal detachment or bacterial infection.
Photodynamic therapy
This specialised treatment combines a light-activated drug called verteporfin with laser therapy to selectively destroy abnormal blood vessels whilst minimising damage to healthy tissue. Though less commonly used since the advent of anti-VEGF therapy, it remains valuable for certain types of wet AMD.
Thermal laser therapy
In specific cases involving well-defined abnormal blood vessels located away from the central macula, thermal laser treatment may be used to seal leaking vessels. However, this approach carries a risk of creating immediate vision loss and is reserved for carefully selected cases.
Comparing dry and wet AMD: Which poses the greater threat?
The question of which form of AMD is “worse” requires careful consideration of multiple factors, including disease progression, treatment options, and long-term prognosis.
Disease progression and timeline
- Dry AMD progression: The gradual nature of dry AMD progression often provides a psychological advantage, allowing individuals time to adapt to vision changes and implement lifestyle modifications. Many people with dry AMD maintain functional vision for years or even decades, particularly when the disease affects only one eye initially.
- Wet AMD progression: Wet AMD can quickly lead to total loss of central vision, sometimes within weeks or months of onset. This rapid progression makes early detection and immediate treatment absolutely critical for preserving vision.
Treatment effectiveness and outcomes
- Dry AMD treatment limitations: The absence of proven medical treatments for dry AMD beyond nutritional supplementation and lifestyle modification means that the disease will likely continue progressing, albeit potentially at a slower rate.
- Wet AMD treatment success: Modern anti-VEGF therapy has dramatically improved outcomes for wet AMD patients. Studies show that approximately 30-40% of patients experience vision improvement, whilst 60-70% maintain stable vision when treated promptly and consistently.
Risk of progression
A crucial consideration is that any stage of dry AMD can turn into wet AMD, with approximately 10-15% of people with dry AMD eventually developing the wet form. This progression typically occurs in the advanced stages of dry AMD and may affect one or both eyes.
Functional impact on daily life
Both forms of AMD significantly impact quality of life, but in different ways:
- Dry AMD impact: The gradual vision loss allows for adaptation and the implementation of visual aids and environmental modifications. Many individuals successfully maintain independence with appropriate support.
- Wet AMD impact: The sudden onset and potential for rapid, severe vision loss can be emotionally devastating and may require immediate lifestyle adjustments. However, successful treatment can halt or reverse vision loss.
The real-world implications of living with AMD
Understanding the practical impact of AMD on daily activities helps put the “which is worse” question into perspective.
Impact on driving
Both forms of AMD can significantly affect driving ability, but the timeline differs markedly. Dry AMD typically allows for gradual adaptation, with individuals slowly adjusting their driving habits—avoiding night driving, unfamiliar routes, or challenging conditions. Wet AMD, however, may suddenly make driving unsafe, requiring immediate cessation of driving until treatment stabilises vision.
UK driving regulations require individuals to inform the DVLA of any condition that might affect their driving ability, including AMD. Regular vision assessments become crucial for maintaining driving privileges safely.
Reading and close work
The impact on reading varies significantly between the two forms. Dry AMD often allows continued reading with magnification, enhanced lighting, and large-print materials. The gradual progression provides time to learn new techniques and acquire helpful devices.
Wet AMD may render reading impossible without treatment, but successful anti-VEGF therapy can often restore reading ability. The key lies in seeking treatment before permanent damage occurs.
Social and emotional implications
Both forms of AMD can lead to social isolation, depression, and anxiety about the future. However, the different progression patterns create distinct challenges:
- Dry AMD allows time for emotional adjustment and the development of coping strategies
- Wet AMD’s sudden onset can be traumatic and may require immediate psychological support.
Employment considerations
For individuals still working when AMD develops, the impact depends greatly on job requirements and the form of AMD present. Office workers may find computer adaptations helpful for dry AMD, whilst wet AMD might require immediate workplace accommodations or medical leave.
Related read: What Jobs Require Perfect Vision?
Emerging treatments and future hope
Research into AMD treatments continues at a rapid pace, offering hope for improved outcomes in the future.
Gene therapy
Several gene therapy approaches are under investigation for both dry and wet AMD. These treatments aim to provide sustained therapeutic effects through single injections, potentially reducing treatment burden.
Stem cell therapy
Research into using stem cells to replace damaged retinal cells shows promise, particularly for dry AMD. Clinical trials are investigating various approaches, including embryonic stem cells and induced pluripotent stem cells.
Artificial retina technology
For individuals with advanced AMD, artificial retina devices may eventually provide some restoration of functional vision. Several devices are in various stages of development and testing.
Complement system inhibitors
New treatments targeting the complement system—part of the immune system implicated in AMD development—are showing promise for both preventing and treating AMD.
The verdict: Understanding relative severity
So, which is worse – dry or wet macular degeneration? The answer depends largely on perspective and timeline:
- In terms of immediate threat to vision: Wet AMD poses the greater immediate danger due to its potential for rapid, severe vision loss. The aggressive nature of abnormal blood vessel growth and leakage can destroy central vision within weeks or months without treatment.
- In terms of treatment options: Paradoxically, wet AMD often has better treatment prospects than dry AMD. Anti-VEGF therapy can halt progression and sometimes improve vision, whilst dry AMD currently lacks proven medical treatments beyond nutritional support.
- In terms of long-term outlook: Both conditions can significantly impact quality of life, but the different progression patterns create distinct challenges and opportunities for adaptation.
- In terms of prevalence: Dry AMD affects far more people and represents the pathway through which most individuals develop wet AMD, making it a significant public health concern.
The most important perspective, however, is that both conditions require prompt attention and ongoing management. Early detection, appropriate treatment when available, and proactive lifestyle modifications can significantly improve outcomes for both forms of AMD.
Your next steps…
If you’re concerned about macular degeneration or have been diagnosed with either form of AMD, consider these important steps:
- Schedule regular comprehensive eye examinations with an optometrist or ophthalmologist experienced in retinal diseases
- Learn to use the Amsler grid for daily monitoring of vision changes, particularly if you have dry AMD
- Implement evidence-based lifestyle modifications including smoking cessation, improved nutrition, UV protection, and regular exercise
- Seek immediate medical attention if you experience sudden vision changes, particularly distortion of straight lines or rapid worsening of central vision
- Connect with support services early to learn adaptive strategies and access helpful resources
- Consider nutritional supplementation if you have intermediate-stage dry AMD, following consultation with your eye care professional
- Stay informed about new treatments and research developments that may benefit your specific situation.
Remember that whilst both dry and wet macular degeneration present significant challenges, neither represents the end of an active, independent life. With proper management, regular monitoring, and appropriate support, many individuals with AMD continue to live fulfilling lives whilst maintaining their independence and pursuing their interests.
The question of which form is “worse” ultimately matters less than ensuring you receive appropriate care for whichever form you may have. Both dry and wet AMD benefit from early detection, proper treatment when available, and proactive management strategies that can help preserve your precious gift of sight for years to come.
Complete our FREE macular degeneration quiz!
Learn more about macular degeneration and receive expert supplement advice in under a minute.
Take the quiz!
This information is provided for educational purposes and should not replace professional medical advice. Always consult with an eye care professional for personalised guidance regarding your specific situation.